Sign In
Buy AVNS
$24.99
+0 (+0%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Avanos Medical, Inc. for Potential Breach of Fiduciary Duty Claims
07:48pm, Wednesday, 18'th Mar 2020
NEW YORK, March 18, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc..
Avanos Medical Inc (NYSE:AVNS) Short Interest Update
08:44am, Monday, 16'th Mar 2020
Avanos Medical Inc (NYSE:AVNS) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,230,000 shares, a gro
Avanos Medical (NYSE:AVNS) Trading Down 9.8%
08:02am, Friday, 13'th Mar 2020
Avanos Medical Inc (NYSE:AVNS) was down 9.8% during mid-day trading on Wednesday . The stock traded as low as $28.62 and last traded at $29.01, approximately 589,213 shares were traded during mid-day
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Edited Transcript of AVNS earnings conference call or presentation 25-Feb-20 2:00pm GMT
10:02am, Tuesday, 10'th Mar 2020
Q4 2019 Avanos Medical Inc Earnings Call
Avanos Medical Inc (NYSE:AVNS) Expected to Announce Earnings of $0.17 Per Share
10:10am, Sunday, 08'th Mar 2020
Brokerages forecast that Avanos Medical Inc (NYSE:AVNS) will report $0.17 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for
Contrasting Ocugen (NASDAQ:OCGN) & Avanos Medical (NASDAQ:AVNS)
07:04am, Sunday, 08'th Mar 2020
Ocugen (NASDAQ:OCGN) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst r
Avanos Medical Inc (NYSE:AVNS) Expected to Announce Quarterly Sales of $178.57 Million
06:24am, Saturday, 07'th Mar 2020
Analysts expect Avanos Medical Inc (NYSE:AVNS) to announce $178.57 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for A
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
11:30am, Wednesday, 04'th Mar 2020
Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
Barclays PLC Purchases 77,759 Shares of Avanos Medical Inc (NYSE:AVNS)
10:52am, Wednesday, 04'th Mar 2020
Barclays PLC raised its position in Avanos Medical Inc (NYSE:AVNS) by 317.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 102,254 shares of the compa
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
05:30am, Wednesday, 04'th Mar 2020
Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
Barclays Reiterates Sell Rating for Avanos Medical (NYSE:AVNS)
10:04am, Monday, 02'nd Mar 2020
Barclays reiterated their sell rating on shares of Avanos Medical (NYSE:AVNS) in a research note issued to investors on Thursday, AnalystRatings.com reports. Barclays currently has a $32.00 target pri
Essex Investment Management Co. LLC Trims Position in Avanos Medical Inc (NYSE:AVNS)
12:24pm, Saturday, 29'th Feb 2020
Essex Investment Management Co. LLC cut its stake in shares of Avanos Medical Inc (NYSE:AVNS) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities
Avanos Medical Inc Expected to Earn Q1 2020 Earnings of $0.15 Per Share (NYSE:AVNS)
07:16am, Saturday, 29'th Feb 2020
Avanos Medical Inc (NYSE:AVNS) – KeyCorp issued their Q1 2020 earnings estimates for Avanos Medical in a research report issued on Tuesday, February 25th. KeyCorp analyst M. Mishan forecasts that th
